These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2860658)

  • 1. Prevalence of tardive dyskinesia in a clinic population.
    Fleischhauer J; Kocher R; Hobi V; Gilsdorf U
    Psychopharmacology Suppl; 1985; 2():162-72. PubMed ID: 2860658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curaçao extrapyramidal syndromes study V.
    van Harten PN; Hoek HW; Matroos GE; van Os J
    J Clin Psychiatry; 2006 Dec; 67(12):1920-7. PubMed ID: 17194270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
    Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
    Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study.
    Ganzini L; Heintz RT; Hoffman WF; Casey DE
    Arch Gen Psychiatry; 1991 Mar; 48(3):259-63. PubMed ID: 1671743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buspirone in the treatment of tardive dyskinesia.
    Moss LE; Neppe VM; Drevets WC
    J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of subtyping tardive dyskinesia: a study of prevalence and associated factors.
    Gureje O
    Psychol Med; 1989 Feb; 19(1):121-8. PubMed ID: 2567019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of tardive dyskinesia among psychiatric in-patients at Mathari Hospital, Nairobi.
    Gatere N; Othieno CJ; Kathuku DM
    East Afr Med J; 2002 Oct; 79(10):547-9. PubMed ID: 12635762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis.
    Apud JA; Egan MF; Wyatt RJ
    Schizophr Res; 2003 Sep; 63(1-2):151-60. PubMed ID: 12892869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Handedness and the risk of tardive dyskinesia.
    Morgenstern H; Glazer WM; Doucette JT
    Biol Psychiatry; 1996 Jul; 40(1):35-42. PubMed ID: 8780853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic-induced tardive dyskinesia among Arab psychotic patients.
    Osman A; Marghalani M; Turkistani IY; Al-Swaf M; Bin Sadiq B
    East Mediterr Health J; 2007; 13(3):625-32. PubMed ID: 17687836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of tardive dyskinesia: results of a cross-sectional study in an outpatient population.
    Morgenstern H; Glazer WM; Gibowski LD; Holmberg S
    J Chronic Dis; 1987; 40(4):319-27. PubMed ID: 2881941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year outcome of tardive dyskinesia.
    Gardos G; Casey DE; Cole JO; Perenyi A; Kocsis E; Arato M; Samson JA; Conley C
    Am J Psychiatry; 1994 Jun; 151(6):836-41. PubMed ID: 7910437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New findings on tardive dyskinesia in a community sample.
    O'Hara P; Brugha TS; Lesage A; Wing J
    Psychol Med; 1993 May; 23(2):453-65. PubMed ID: 8101384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of tardive dyskinesia among three ethnic groups of chronic psychiatric patients.
    Sramek J; Roy S; Ahrens T; Pinanong P; Cutler NR; Pi E
    Hosp Community Psychiatry; 1991 Jun; 42(6):590-2. PubMed ID: 1677921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of tardive dyskinesia in the elderly: rates and risk factors.
    Woerner MG; Alvir JM; Saltz BL; Lieberman JA; Kane JM
    Am J Psychiatry; 1998 Nov; 155(11):1521-8. PubMed ID: 9812112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tardive dyskinesia: reversible and irreversible.
    Casey DE
    Psychopharmacology Suppl; 1985; 2():88-97. PubMed ID: 2860664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication.
    Glazer WM; Morgenstern H; Schooler N; Berkman CS; Moore DC
    Br J Psychiatry; 1990 Oct; 157():585-92. PubMed ID: 1983390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive dyskinesia in northern Israel: preliminary study.
    Schwartz M; Silver H; Tal I; Sharf B
    Eur Neurol; 1993; 33(3):264-6. PubMed ID: 8096816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.